This framework divides NETs into three grades: low-grade (G1, Ki-67 < 3%), intermediate-grade (G2, Ki-67 3–10%), and high-grade (G3, Ki-67 > 20%), reflecting the tumor’s aggressiveness and prognosis [13]. This evidence concerns the gene MKI67 and neoplasm.